Avidity Partners Management LP Has $13.04 Million Stock Holdings in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)

Avidity Partners Management LP increased its position in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) by 5.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,673,538 shares of the company’s stock after purchasing an additional 92,396 shares during the […]

Related Keywords

Piper Sandler ,Securities Exchange Commission ,Syros Pharmaceuticals Profile ,Syros Pharmaceuticals ,Bain Capital Life Sciences Investors ,Syros Pharmaceuticals Stock Performance ,Syros Pharmaceuticals Inc ,News Ratings For Syros Pharmaceuticals Daily ,Nasdaq ,Quarter For Syros Pharmaceuticals ,Avidity Partners Management ,Free Report ,Partners Management ,Capital Life Sciences Investors ,Get Free Report ,Visit Holdingschannel ,Syros Pharmaceuticals Daily ,